Hai M Nguyen Selected Research

Peptides (Polypeptides)

1/2023	Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke.
12/2022	Computational design of peptides to target NaV1.7 channel with high potency and selectivity for the treatment of pain.
9/2014	Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.
6/2012	Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hai M Nguyen Research Topics

Disease

5	Ischemic Stroke 04/2023 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2017
5	Neuroinflammatory Diseases 12/2021 - 12/2016
4	Infarction (Infarctions) 04/2023 - 12/2016
4	Inflammation (Inflammations) 04/2023 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 09/2014
3	Stroke (Strokes) 01/2023 - 12/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2023 - 12/2016
2	Sickle Cell Anemia (Hemoglobin S Disease) 04/2023 - 04/2019
2	Pain (Aches) 12/2022 - 01/2015
1	Temporal Lobe Epilepsy 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023
1	Reperfusion Injury 01/2023
1	Ataxia (Dyssynergia) 01/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022
1	Cerebellar Ataxia (Dysmetria) 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021
1	Parkinson Disease (Parkinson's Disease) 12/2021
1	Hypoxia (Hypoxemia) 01/2018
1	Animal Disease Models 07/2017
1	Epilepsy (Aura) 07/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2017
1	Ischemia 12/2016
1	Acute Pain 01/2015
1	Tremor (Tremors) 04/2014
1	Colorectal Neoplasms (Colorectal Cancer) 03/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2012
1	Multiple Sclerosis 06/2012

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 01/2023 - 06/2012
4	Potassium Channels (Potassium Channel)IBA 01/2021 - 12/2016
2	CytokinesIBA 04/2023 - 01/2017
2	senicapocIBA 04/2023 - 04/2019
2	PotassiumIBA 01/2022 - 09/2014
2	Kv1.3 Potassium ChannelIBA 12/2021 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 04/2019 - 01/2018
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 04/2023
1	Dihydrotachysterol (AT 10)IBA 04/2023
1	2-aminothiazoleIBA 01/2023
1	Kainic Acid (Kainate)IBA 01/2023
1	Riluzole FDA LinkGeneric 01/2023
1	SodiumIBA 12/2022
1	CalciumIBA 01/2022
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	NS 1619IBA 01/2022
1	Purinergic P2X4 ReceptorsIBA 11/2020
1	AntigensIBA 08/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	InterferonsIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	TRAM 34IBA 12/2016
1	Formaldehyde (Formol)FDA Link 01/2015
1	bifenthrinIBA 04/2014
1	Pyrethrins (Pyrethroids)FDA Link 04/2014
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2012

Therapy/Procedure

6	Therapeutics 04/2023 - 06/2012
1	Thrombectomy 01/2023
1	Ligation 01/2015
1	Immunomodulation 09/2014